Cancers are masters of disguise that can evade the immune system, growing undetected while wreaking havoc on the body. However, a new approach using oncolytic bacteria – bacteria that target and destroy cancer cells – may offer a way to expose and attack these tumors. When oncolytic bacteria are introduced into a tumor, the immune […]

Understanding Cancer Through DNA Damage and Repair Bongsup Cho and Deyu Li study how DNA damage and repair shape cancer risk and mutation patterns At the University of Rhode Island, Bongsup Cho, Ph.D., professor, and Deyu Li, Ph.D., associate professor, lead a collaborative research program focused on how chemical damage to DNA contributes to cancer. […]

URI Neuroscientist Explores Retinal Scanning to Detect Early-Stage Alzheimer’s URI researcher Jessica Alber is advancing retinal imaging as a low-cost, minimally invasive tool for early Alzheimer’s detection Jessica Alber, Ph.D., associate professor of biomedical and pharmaceutical sciences and George and Anne Ryan Institute for Neuroscience faculty member at the University of Rhode Island, is working […]

Using Artificial Intelligence (AI) to Understand Chronic Kidney Disease Todd Brothers uses AI to uncover patterns in kidney disease that could transform care Chronic kidney disease (CKD) affects millions of people worldwide and is a major contributor to cardiovascular complications, hospitalization and premature death. Yet the disease often develops gradually and presents differently across patients, […]

Whenever a patient presents with a bacterial gastrointestinal illness, the common response is to prescribe an antibiotic that kills the disease-causing bacteria, allowing the patient to recover. While effective, they often eliminate not only harmful bacteria but also beneficial microbes that support digestion and overall health. Amanda Alker, Ph.D., assistant professor at the University of […]

Metabolic diseases, including obesity, Type 2 diabetes, metabolic dysfunction-associated steatotic liver disease (MASLD) and related cardiovascular conditions, represent one of the most urgent public health challenges of the 21st century. These disorders affect hundreds of millions of people worldwide and impose a significant clinical and economic burden. Despite advances in therapeutic options, significant gaps remain […]

Continuous glucose monitoring, or CGM, is an increasingly used technology that provides real-time glucose data to help manage diabetes. Despite its growing use, insurance coverage and cost remain barriers for some patients. In a study involving researchers from the University of Rhode Island College of Pharmacy, clinic-based professional CGM (proCGM) was evaluated in a care […]

Why certain parts of the brain are more vulnerable to aging and disease remains one of the most important questions in neuroscience. At the University of Rhode Island College of Pharmacy, Merina Varghese, assistant professor of biomedical and pharmaceutical sciences and George and Anne Ryan Institute for Neuroscience faculty member, is investigating the cellular and […]

Pharmacist-Led Research Advancing Diabetes and Cardiovascular Care Tracey Taveira advances team-based care models to improve outcomes in cardiometabolic disease Cardiovascular disease and diabetes remain leading causes of illness and death worldwide, particularly among vulnerable populations. Improving outcomes for these patients requires new care models that address both medical and social factors influencing health. At the […]

Expecting Protection: Evaluating Vaccinations in Pregnancy Virginia Lemay studies vaccine hesitancy and maternal health education Despite recommendations from leading public health organizations that many vaccines are safe and effective for pregnant women, vaccine hesitancy among this population remains high throughout the United States. Virginia Lemay, Pharm.D., clinical professor at the University of Rhode Island, is […]